Magnesium in cardioplegia: Is it necessary?

Canadian Journal of Surgery

Volumn 39, Issue 5, 1996, Pages 397-400

  Shakerinia, Tooraj ^a,b   Ali, Idris M ^a   Sullivan, John A P ^a  

^a Victoria GenerarHospitat   (United States)

^b Victoria Gênent Hospital

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; MAGNESIUM;

ADULT; AGED; ARTICLE; CARDIOPLEGIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DRUG EFFICACY; FEMALE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; MALE; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL;

AGED; ARRHYTHMIA; CARDIOPLEGIC SOLUTIONS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INTRAOPERATIVE COMPLICATIONS; MAGNESIUM; MAGNESIUM SULFATE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POSTOPERATIVE COMPLICATIONS;

EID: 0029831086     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Reynolds TR, Geffin GA, Titus JS, O'Kecfe DD, Daggett WM. Myocardial preservation related to magnesium content of hyperkalemic cardioplegic solutions at 8 degrees C. Aim Tljorac Suty 1989;47:907-13.
2. Brown PS Jr, Holland RV, Parenteau GL, Clarke RE. Magnesium ion is beneficial in hypothermie crystalloid cardioplegia. Ann Tliorac Surg 1991; 51:359-67.
3. Takemoto N, Kuroda H, Hamasaki T, Hara Y, Ishiguro S, Mori T. Effect of magnesium and calcium on myocardial protection by cardioplegic solutions. Ann Thornc Sttrtj 1994; 57:177-82.
4. Geffin GA, Love TR, Hendren WG, Torchiana DF, Titus JS, Redonnett BE, et al. The effects of calcium and magnesium in hyperkalemic cardioplegic solutions on myocardial preservation [see comment]. JTIjorac Cardiovnsc Surjj 1989;98:239-50. Comment in: / Tliorac Cardiovnsc Surg 1989;98:289-91.
5. Sager PT, Widerhorn J, Petersen R, Leon C, Ryzen E, Rüde R, et al. Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supravcntricular tachycardia. Am Heart} 1990;! 19(2 Pt 1):308-16.
6. Horner SM. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction. Circulation 1992;86:774-9.
7. Vigorito C, Giordana A, Ferraro P, ; Acanfora D, Cc Caprio L, Naddeo C, ; et al. Hemodynamic effects of magnesium sulfate on normal human heart. ; AmJCardiol 1991;67:1435-7.
8. Brooks CI, Fry CH. Ionized magnesium and calcium in plasma from healthy volunteers and patients undergoing cardiopulmonary bypass. Br Hirt/1993;69:404-8.
9. Lareau S, Boyle A, Deslauriers R, Keon WJ, Kroft T, Labow RS. Magnesium enhances function of postischaemic human myocardial tissue. Cardiovasc Res 1993;27:1009-14.
10. Schwinger RH, Bohm M, Uhlmann R, Schmid U, Uberfuhr P, Kreuzer E, et al. Magnesium restores the altered force-frequency relationship in failing human myocardium. Am Hmrt71993;126:1018-21.
11. Kulick DL, Hong R, Ryzen E, Rude RK, Rubin JM, Elkayam U, et al. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease. Am Heart] 1988;115:367-72.
12. Iseri LT. Magnesium and cardiac arrhythmias [review]. Magnesium 1986; 5:111-26.